Results 61 to 70 of about 20,763 (194)
Update on imaging of ovarian cancer [PDF]
, 2016 This review will make familiar with new concepts in ovarian cancer and their impact on radiological practice. Disseminated peritoneal spread and ascites are typical of the most common (70–80 %) cancer type, highgrade serous ovarian cancer.
Cunha, Teresa Margarida +2 more
core +1 more source
Journal of Ovarian Research, 2020 Objective The aim of this study is to establish a noninvasive preoperative model for predicting primary optimal cytoreduction in advanced epithelial ovarian cancer by HE4 and CA125 combined with clinicopathological parameters.
Li-yuan Feng, Sheng-bin Liao, Li Li
doaj +1 more source
Case Reports in Oncology, 2020 Myeloproliferative neoplasms including essential thrombocythemia (ET) is usually caused by somatic mutations in multiple genes, including the JAK2 (most frequently), CALR gene, and MPL. In rare cases, the disease is caused by other mutations such as THPO
Mohammad Abu-Tineh, Mohamed A. Yassin
doaj +1 more source
Intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis: is HIPEC the only answer? [PDF]
, 2014 Gastric cancer with peritoneal carcinomatosis is notorious for its dismal prognosis. While the pathophysiology of peritoneal dissemination is still controversial, the rapid downhill course is universal.
Kwong, DLW, Lam, KO, Law, BTT, Law, SYK
core +1 more source
İstanbul Medical Journal, 2019 Introduction:To compare long-term survival of primary debulking surgery (PDS) and interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) in patients with advanced ovarian cancer.Methods:Patients who underwent debulking surgery for ovarian ...
Alpaslan Kaban +3 more
doaj +1 more source
Optimizing the primary treatment of patients with advanced ovarian cancer
Опухоли женской репродуктивной системы, 2016 In this article we analyzed the issues of optimizing the upfront debulking surgery for patients with advanced ovarian cancer. We reviewed the recent evidence highlighting the actual concerns of using neoadjuvant chemotherapy aiming to reduce the tumor ...
S. O. Nikogosyan +3 more
doaj +1 more source
ESTIMATION OF SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER – ABSTRACT OF THE RESEARCH PROJECT
Zdravniški Vestnik, 2018 Background: Morbidity and mortality caused by cancer persist to be an important health problem world- wide and in the European Union member states as well.
Špela Smrkolj +6 more
doaj +1 more source
Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors [PDF]
, 2009 ObjectiveThis study aimed to evaluate the perioperative and long-term outcomes associated with extrapleural pneumonectomy for patients with malignant pleural mesothelioma.MethodsFrom October 1994 to April 2008, 70 patients were selected for extrapleural ...
Bannon, Paul G. +7 more
core +1 more source
Cancer immunotherapy as a new treatment option [PDF]
, 2019 Cancer can coaptate the immune control of the immune system (IS), evade immunity and its destruction. So, could we say openly that immunotherapy is a viable treatment option for patients with advanced cancer?
Alonso-Ortiz, Antonio +2 more
core
Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]
, 2018 Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas +5 more
core +1 more source